Clinical Trial Update: Epirubicin and Thalidomide in Treating Patients With Liver Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating epirubicin in combination with thalidomide for liver cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Epirubicin (epirubicin)
• Thalidomide (thalidomide)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Liver Cancer | Phase 2 | Status: COMPLETED